Explore key findings on Medicare Part D cancer drug denials, overturn rates, and the need for improved appeals processes from a recent study.

Explore the ongoing challenges of PBS drug misuse in Australia, including implications for healthcare regulation and the critical need for effective management strategies.

Explore critical updates in U.S. healthcare regulations, insurance market dynamics, and innovations in patient care including AI and new billing practices

Discover CMS's draft guidance on Medicare drug pricing, impacting stakeholders and beneficiaries, designed to streamline processes and enhance compliance.

Explore Johnson & Johnson's second quarter performance and insights on medical device sales, market dynamics and the impact of healthcare demand.

Learn about HHS OIG's progress in combating healthcare fraud, major actions, and legislative developments addressing Medicaid and Medicare spending.

Tonix Pharmaceuticals expands Medicare coverage for TONMYA®, improving access for 9M beneficiaries. Discover innovations in fibromyalgia treatments.

Discover how the new Medicare GLP-1 Bridge program improves access to weight loss medications for millions of Americans. Learn more about eligibility and benefits.

Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.

Explore the surge in GLP-1 medication use and the Medicare Bridge program enabling easier access for eligible individuals in weight management.